Pipotiazine Palmitate
Specifications
37517-26-3CAS Number
253-536-4EC Number
2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl hexadecanoateIUPAC Name
C40H63N3O4S2Chemical Formula
714.1 g/molMolecular Weight
PIPOTIAZINE PALMITATE; 37517-26-3; Pipothiazine palmitate; Pipotiazine Palmitic Ester; Piportil depot; RP 19552; DTXSID5048970; RP-19552; 4Q3H01QRMI; Pipothiazin palmitate; 19552 RP; IL-19552; DTXCID8028896; 10-(3-(4-(2-Hydroxyethyl)piperidino)propyl)-N,N-dimethylphenothiazine-2-sulfonamide palmitate (ester); Hexadecanoic acid, 2-(1-(3-(2-((dimethylamino)sulfonyl)-10H-phenothiazin-10-yl)propyl)-4-piperidinyl)ethyl ester; 10-[3-[4-(2-Hydroxyethyl)piperidino]propyl]-N,N-dimethylphenothiazine-2-sulfonamide palmitate (ester); RefChem:174475; 253-536-4; Pipotiazine palmitate [USAN]; IL 19552; 2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl hexadecanoate; NCGC00182048-01; Pipotiazine palmitate (USAN); C40H63N3O4S2; EINECS 253-536-4; UNII-4Q3H01QRMI; Pipotiazin Retard; pipotiazine-palmitate; Pipotiazine Palmintate; Piportil depot (TN); SCHEMBL636669; orb3174098; CHEMBL2106439; SCHEMBL29414111; CHEBI:135769; KTOYYUONFQWSMW-UHFFFAOYSA-N; Tox21_113420; PIPOTIAZINE PALMITATE [MART.]; AKOS015962982; PIPOTIAZINE PALMITATE [WHO-DD]; AC-1270; FP27077; PIPOTIAZINE PALMITIC ESTER [MI]; 2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]-4-piperidyl]ethyl hexadecanoate; 2-(1-(3-(2-((Dimethylamino)sulphonyl)-10H-phenothiazin-10-yl)propyl)piperidin-4-yl)ethyl palmitate; 2-(1-{3-[2-(dimethylsulfamoyl)-10H-phenothiazin-10-yl]propyl}piperidin-4-yl)ethyl hexadecanoate; CAS-37517-26-3; NS00030206; D02680; SBI-0654154.0001; SR-01000944866; SR-01000944866-1; BRD-K48429278-001-01-3; Q27260354; 10-[3-[4-(2-Hydroxyethyl)-1-piperidinyl]propyl]-N ,N-dimethyl-10H-phenothiazine-2-sulfonamide palmitic esterSynonyms
